Pharmaceuticals

Global Drug Repurposing Market Performance Report: Global Trends 2026–2030

February 13, 2026February 13, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the drug repurposing market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Drug Repurposing Market?

The drug repurposing market has experienced robust expansion in recent times. Projections indicate its size will increase from $37.38 billion in 2025 to $40.95 billion by 2026, demonstrating a compound annual growth rate (CAGR) of 9.6%. Historically, this growth has been driven by several factors, including the significant expense and lengthy timelines associated with conventional drug discovery, a growing count of unsuccessful drug candidates, the increasing occurrence of chronic and rare diseases, insufficient treatment options for novel diseases, and the prompt integration of computational techniques for drug repositioning.

The drug repurposing market is projected to experience substantial expansion in the coming years, with its size expected to reach $58.33 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This anticipated growth during the forecast period is fueled by several factors, including the incorporation of AI and machine learning into drug repurposing, increased investment in biotechnology and pharmaceutical research, the broadening capabilities of contract research organizations (CROs), an escalating need for economical treatments, and favorable regulatory frameworks for repurposed drug approvals. Key trends expected within this period encompass a heightened emphasis on phenotypic and target-based screening methods, the growing acceptance of structure-based drug repositioning, advancements in identifying off-target activities, the extended application of drug repurposing for treating rare and infectious diseases, and the reduction of drug development timelines by utilizing existing molecules.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25758&type=smp

Which Drivers Are Supporting The Rise Of The Drug Repurposing Market?

The increasing incidence of neurodegenerative conditions is anticipated to drive expansion in the drug repurposing market in the future. These diseases encompass a category of ailments marked by the gradual deterioration of neuron structure or function, leading to their demise. The escalation in conditions such as Alzheimer’s dementia is linked to extended life expectancy, given that aging serves as the primary contributing factor to the slow degradation of neuronal activity over time. Drug repurposing aids in addressing neurodegenerative diseases by pinpointing established medications with verified safety records that can be re-channeled to target disease mechanisms, thereby expediting the creation of efficacious therapies. As an illustration, in March 2023, the Alzheimer’s Association, a US-based nonprofit voluntary health organization, reported that approximately 6.7 million Americans aged 65 and older are currently afflicted with Alzheimer’s dementia in 2023, with forecasts suggesting this figure will climb to 13.8 million by 2060. Consequently, the expanding occurrence of neurodegenerative conditions is fueling the expansion of the drug repurposing market.

What Segments Are Identified Within The Structure Of The Drug Repurposing Market?

The drug repurposing market covered in this report is segmented –

1) By Type: Disease-Centric, Target-Centric, Drug-Centric

2) By Drug Molecules: Biologics, Small Molecule

3) By Therapeutic Area: Oncology, Neurology, Infectious Diseases, Cardiovascular Diseases, Autoimmune Disorders

4) By Route Of Administration: Oral, Intravenous, Topical, Inhalation, Intramuscular

5) By End-User: Pharmaceutical Companies, Research And Academic Institutes, Contract Research Organizations

Subsegments:

1) By Disease-Centric: Phenotypic Screening, Epidemiological Analysis, Clinical Observation-Based Repurposing

2) By Target-Centric: Protein Target Modulation, Pathway Modulation, Biomarker-Based Targeting

3) By Drug-Centric: Off-Target Activity Identification, Structure-Based Drug Repositioning, Adverse Effect-Based Repurposing

Which Innovation Trends Are Advancing Developments Within The Drug Repurposing Market?

Major companies active in the drug repurposing market are concentrating on developing advanced technologies, such as artificial intelligence (AI)-powered drug-protein interaction modeling, to quicken the identification of new treatment uses for current drugs. Artificial intelligence (AI)-powered drug-protein interaction modeling utilizes AI and machine learning to predict how drugs engage with proteins across the entire human proteome, employing vast datasets to improve accuracy and certainty. For example, in July 2025, Cosmos Health Inc., a healthcare company based in the US, introduced Cloudscreen 2.0, an innovative AI platform for drug repurposing. This next-generation system is built to handle datasets over 100 times larger than previous versions, enabling thorough analysis of drug-protein interactions. By integrating mutagenesis data and tools for analyzing disordered proteins, the platform targets illnesses such as cancer, obesity, and diabetes. Furthermore, graphics processing unit (GPU)-based cloud computing facilitates scalable processing, making the platform a crucial advancement in accelerating research and development efforts for drug repurposing across various therapeutic fields.

Which Leading Companies Dominate The Drug Repurposing Market Share?

Major companies operating in the drug repurposing market are F. Hoffmann-La Roche Ltd , Bayer AG, Takeda Pharmaceutical Company Limited, Amgen Inc., Teva Pharmaceutical Industries Limited, Astellas Pharma Inc., UCB S.A., Eisai Co Ltd., Celltrion Inc., Evotec SE, BenevolentAI Limited, Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Pharnext S.A., Healx Ltd., Algernon Pharmaceuticals Inc., BioXcel Therapeutics Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/drug-repurposing-global-market-report

How Does The Drug Repurposing Market Perform Across Major Global Regions?

North America was the largest region in the drug repurposing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug repurposing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Drug Repurposing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25758&type=smp

Browse Through More Reports Similar to the Global Drug Repurposing Market 2026, By The Business Research Company

Pharmacy Repackaging Systems Market Report 2026

https://www.thebusinessresearchcompany.com/report/pharmacy-repackaging-systems-global-market-report

Music Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/music-therapy-global-market-report

Personal Development Market Report 2026

https://www.thebusinessresearchcompany.com/report/personal-development-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795